Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Dexmedetomidine Versus Ketofol For Moderate Sedation In Endoscopic Retrograde Cholangiopancreatography (ERCP): A Randomized Controlled Trial

NCT06212401 is registered in ClinicalTrials.gov with Sindh Institute of Urology and Transplantation as lead sponsor.

NCT NCT06212401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06212401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Dexmedetomidine Versus Ketofol For Moderate Sedation In Endoscopic Retrograde Cholangiopancreatography (ERCP): A Randomized Controlled Trial
Lead sponsor
Sindh Institute of Urology and Transplantation
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2021
Completion date
June 30, 2022
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sedation